Abstract
Objectives: Find possible causative agents causing cutaneous adverse reactions; clinical patterns, causality and severity of Drug induced cutaneous adverse reactions (CADR) and treatment outcome.
Methods: Retrospective study was undertaken including cases of CADR. Causality, preventability and severity of Drug Induced cutaneous reactions were judged with the use of Naranjo's algorithm, WHO causality scale, modified Schumock and Thorton scale, and Hartwig’s scale respectively. Results: Among 275 total cADRs reported, Antimicrobials (46.55%) were the main drugs involved followed by Non steroidal anti-inflammatory drugs (NSAIDs) (25.09%) and Antifungal (9.82%). Urticaria (63.64%) followed by Erythema multiform(12.36%) was most frequently observed CDRs. Amongst all cADRs 50.18% were certain according to Naranjo’s scale, none of them were preventable according to modified Schumock and Thorton scale. All reactions were moderate according to Hartwig’s severity scale. Conclusion: It was observed that antibiotics and NSAIDs cause maximum number of CADRs. Therefore strict vigilance is required while using them.Keywords: Adverse cutaneous drug reactions, Antimicrobials, NSAIDS, Urticaria.
Current Drug Safety
Title:A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending a Tertiary Care Hospital
Volume: 12 Issue: 1
Author(s): Khyati Doshi, Radha Yegnanarayan and Neeta Gokhale
Affiliation:
Keywords: Adverse cutaneous drug reactions, Antimicrobials, NSAIDS, Urticaria.
Abstract: Objectives: Find possible causative agents causing cutaneous adverse reactions; clinical patterns, causality and severity of Drug induced cutaneous adverse reactions (CADR) and treatment outcome.
Methods: Retrospective study was undertaken including cases of CADR. Causality, preventability and severity of Drug Induced cutaneous reactions were judged with the use of Naranjo's algorithm, WHO causality scale, modified Schumock and Thorton scale, and Hartwig’s scale respectively. Results: Among 275 total cADRs reported, Antimicrobials (46.55%) were the main drugs involved followed by Non steroidal anti-inflammatory drugs (NSAIDs) (25.09%) and Antifungal (9.82%). Urticaria (63.64%) followed by Erythema multiform(12.36%) was most frequently observed CDRs. Amongst all cADRs 50.18% were certain according to Naranjo’s scale, none of them were preventable according to modified Schumock and Thorton scale. All reactions were moderate according to Hartwig’s severity scale. Conclusion: It was observed that antibiotics and NSAIDs cause maximum number of CADRs. Therefore strict vigilance is required while using them.Export Options
About this article
Cite this article as:
Doshi Khyati, Yegnanarayan Radha and Gokhale Neeta, A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending a Tertiary Care Hospital, Current Drug Safety 2017; 12 (1) . https://dx.doi.org/10.2174/157488631201170210194817
DOI https://dx.doi.org/10.2174/157488631201170210194817 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Targets of Diabetic Cardiovascular Complications
Current Drug Targets Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer
Current Vascular Pharmacology Targeting Mitochondria for Cardiac Protection
Current Drug Targets Traditional Risk Factors for Coronary Atherosclerosis in Indo Asians: The Need for a Reappraisal
Current Pharmaceutical Design Hypertension in Egypt: A Systematic Review
Current Hypertension Reviews Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
Current Drug Targets - Cardiovascular & Hematological Disorders Irbesartan: Second Generation of ARB as Metabosartan
Current Hypertension Reviews The Role of Physical Activity in the Development and Prevention of Overweight and Obesity in Childhood
Current Nutrition & Food Science Inhibitors of 11β-Hydroxylase (CYP11B1) for Treating Diseases Related to Excess Cortisol
Current Medicinal Chemistry Current Management of Peripheral Vascular Disease: Where is the Evidence?
Cardiovascular & Hematological Agents in Medicinal Chemistry FTIR Spectroscopy to Study Bioeffects of Static Magnetic Fields on Neuronal-like Cell Cultures
Current Metabolomics Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy
Current Medicinal Chemistry Candidate Circulating Biomarkers for the Cardiovascular Disease Continuum
Current Pharmaceutical Design A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery
Current Vascular Pharmacology Subject Index To Volume 6
Cardiovascular & Hematological Disorders-Drug Targets Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks
Current Pharmaceutical Design Molecular Mechanisms of Several Novel Dipeptides with Angiotensin-Iconverting Enzyme Inhibitory Activity from In-silico Screening of Silkworm Pupae Protein
Current Pharmaceutical Biotechnology Poor Nutrition with Aging: an “Oxidatively Stressing” Condition
Current Nutrition & Food Science Mechanical Circulatory Support in Children
Current Cardiology Reviews Biological Predictors of Aging and Potential of FTIR to Study Age-related Diseases and Aging Metabolic Fingerprint
Current Metabolomics